GHELARDINI, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.663
EU - Europa 49.370
AS - Asia 19.808
SA - Sud America 3.134
Continente sconosciuto - Info sul continente non disponibili 891
AF - Africa 591
OC - Oceania 354
Totale 126.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.676
PL - Polonia 24.760
RU - Federazione Russa 8.821
IT - Italia 6.343
SG - Singapore 5.350
CN - Cina 4.402
HK - Hong Kong 3.191
BR - Brasile 2.533
VN - Vietnam 2.408
IE - Irlanda 2.258
SE - Svezia 1.785
KR - Corea 1.570
DE - Germania 1.097
FI - Finlandia 1.066
FR - Francia 927
GB - Regno Unito 802
UA - Ucraina 757
IN - India 668
CA - Canada 597
ID - Indonesia 408
BD - Bangladesh 364
AU - Australia 343
JP - Giappone 276
JO - Giordania 240
TR - Turchia 233
AR - Argentina 215
NL - Olanda 182
MX - Messico 150
CI - Costa d'Avorio 142
IQ - Iraq 137
ES - Italia 127
ZA - Sudafrica 102
CH - Svizzera 97
EC - Ecuador 95
PK - Pakistan 88
BE - Belgio 83
CO - Colombia 83
NG - Nigeria 59
MA - Marocco 58
VE - Venezuela 55
SA - Arabia Saudita 52
SC - Seychelles 50
JM - Giamaica 46
EG - Egitto 45
PY - Paraguay 44
PT - Portogallo 43
CR - Costa Rica 39
UZ - Uzbekistan 39
PE - Perù 38
PH - Filippine 37
CL - Cile 36
AE - Emirati Arabi Uniti 35
TH - Thailandia 30
AZ - Azerbaigian 29
TN - Tunisia 29
AT - Austria 28
IL - Israele 28
IR - Iran 27
MY - Malesia 27
RO - Romania 27
LT - Lituania 26
NP - Nepal 26
KE - Kenya 25
TW - Taiwan 22
HN - Honduras 21
PR - Porto Rico 21
LB - Libano 20
DZ - Algeria 18
GT - Guatemala 18
AL - Albania 17
TT - Trinidad e Tobago 17
CZ - Repubblica Ceca 16
KZ - Kazakistan 16
UY - Uruguay 16
BG - Bulgaria 14
BO - Bolivia 14
EE - Estonia 14
ET - Etiopia 13
SN - Senegal 13
BJ - Benin 12
OM - Oman 12
SV - El Salvador 12
BB - Barbados 11
DO - Repubblica Dominicana 11
GR - Grecia 11
BH - Bahrain 10
KG - Kirghizistan 10
NZ - Nuova Zelanda 10
NI - Nicaragua 9
AM - Armenia 8
HR - Croazia 8
LV - Lettonia 8
PS - Palestinian Territory 8
DK - Danimarca 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
AO - Angola 6
BY - Bielorussia 6
EU - Europa 6
KW - Kuwait 6
Totale 125.809
Salva come PNG Salva come JPEG
Città #
Warsaw 24.736
Santa Clara 8.636
Ashburn 6.588
Fairfield 4.142
Singapore 3.798
Hong Kong 2.695
Dublin 2.243
San Jose 2.107
Woodbridge 1.955
Chandler 1.954
Seattle 1.754
Cambridge 1.659
Houston 1.530
Seoul 1.436
Wilmington 1.432
Council Bluffs 1.274
Milan 1.221
Jacksonville 1.101
Beijing 1.047
Altamura 739
Ann Arbor 738
Los Angeles 697
Hefei 695
Lawrence 693
The Dalles 664
Princeton 633
Ho Chi Minh City 628
Florence 620
Buffalo 560
Rome 553
Lauterbourg 504
Helsinki 489
Dallas 451
Dong Ket 445
Hanoi 444
Phoenix 414
Mumbai 396
Boston 394
New York 370
Boardman 366
Moscow 361
Jakarta 311
Medford 311
San Diego 300
Melbourne 295
Munich 259
Paris 248
Chicago 244
Tokyo 241
Shanghai 229
São Paulo 208
Kent 154
Clifton 149
London 143
Abidjan 142
Falls Church 141
Naples 134
Turin 131
Orem 127
Philadelphia 126
Izmir 121
Washington 118
Frankfurt am Main 114
Figino 111
Toronto 111
Turku 108
Montreal 103
Bologna 102
Brooklyn 101
Norwalk 100
Redondo Beach 99
Columbus 97
Guangzhou 89
Da Nang 84
Denver 84
Tianjin 84
San Francisco 83
Hillsboro 81
Miano 75
Bern 74
Atlanta 73
Seongnam 73
Brussels 71
Rio de Janeiro 69
Springfield 69
Palermo 68
Haiphong 67
Verona 65
Amsterdam 62
Chennai 59
Baghdad 56
Bari 55
Lappeenranta 53
Abuja 50
Las Vegas 48
Andover 47
Barcelona 47
West Jordan 46
Brasília 45
Genoa 45
Totale 90.162
Salva come PNG Salva come JPEG
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 720
M1 receptor activation is a requirement for arecoline analgesia. 655
LOCAL ANAESTHETIC AVTIVITY OF ESSENTIAL OIL OF LAVANDULA ANGUSTIFOLIA 561
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 540
Antinociceptive property of the nicotinic agonist AG4 in rodents 537
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 501
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 450
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 445
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 432
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 427
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 411
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 408
Ryanodine receptors are involved in muscarinic antinociception in mice. 406
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 406
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 403
Acute effect of Capparis spinosa root extracts on rat articular pain 400
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 392
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 392
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 386
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 381
Neurotransmitter role of endogenous morphine in CNS. 380
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 376
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 373
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 372
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. 370
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 369
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 368
Local anaesthetic activity of beta-caryophyllene. 368
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 366
Synthesis of novel cognition enhancer with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at gamma-aminobutyric acid type A (GABAA) receptor. 365
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 365
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 362
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 360
Design, synthesis and binding affinity of new nicotinic ligands 356
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 354
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 353
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 351
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 351
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 349
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 347
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 346
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 346
Antihyperalgesic activity of verbascoside in the chronic constriction injury of the sciatic nerve (CCI) and intra-articular injection of sodium monoiodoacetate (MIA) models of neuropatic pain 345
Antihyperalgesic activity of verbascoside in two models of neuropathic pain. 344
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 343
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation. 342
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 341
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 340
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 340
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 339
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 338
Delay of morphine tolerance by palmitoylethanolamide 338
Erucin exhibits vasorelaxing effects and antihypertensive activity by H2 S-releasing properties 338
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 337
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 337
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 336
Antisense knockdown of the Shaker Kv1.1 gene family abolishes the central stimulatory effect of amphetamines in mice and rats. 334
The pharmacological basis of opioids 334
LOCAL ANAESTHETIC ACTIVITY OF MONOTERPENES AND PHENYLPROPANES OF ESSENTIAL OILS 333
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 333
Methylamine: a new endogenous modulator of neuron firing? 332
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 331
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 330
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 330
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 329
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 328
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 328
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 328
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 327
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 327
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 326
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 325
Role of intracellular calcium in acute thermal pain perception 325
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 325
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 323
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 323
THE REDUCTION OF FOOD INTAKE INDUCED IN MICE BY BENZYLAMINE AND ITS DERIVATIVES 322
Effect of K+ channel modulation on mouse feeding behaviour 322
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 322
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 322
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 321
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 319
Selenium and zinc: Two key players against cadmium-induced neuronal toxicity. 319
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 316
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 316
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 314
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 313
Prochlorperazine induces central antinociception mediated by the muscarinic system. 313
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 312
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 312
Influence of potassium channel modulators on cognitive processes in mice 311
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 311
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 311
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 311
Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations 311
Contribution of G inhibitory protein alpha subunits in paradoxical hyperalgesia elicited by exceedingly low doses of morphine in mice. 310
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 310
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 310
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 310
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 309
Totale 36.076
Salva come PNG Salva come JPEG
Categoria #
all - tutte 318.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 318.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.313 0 0 0 159 141 239 172 309 262 302 662 1.067
2022/20239.590 964 1.980 444 564 682 1.670 1.325 525 928 59 289 160
2023/20243.915 172 407 670 187 268 562 162 893 83 198 187 126
2024/202525.956 876 2.737 1.729 3.615 7.326 3.327 612 1.429 1.522 778 1.083 922
2025/202632.304 3.036 3.910 2.462 2.629 3.251 1.404 3.588 1.704 2.325 2.216 1.570 4.209
2026/20276.380 1.354 1.235 2.931 860 0 0 0 0 0 0 0 0
Totale 126.811